Literature DB >> 2521461

Changes in integrin receptors on oncogenically transformed cells.

L C Plantefaber1, R O Hynes.   

Abstract

Oncogenically transformed cells show reduced assembly of fibronectin-rich extracellular matrixes and diminished ability to adhere to fibronectin. The molecular bases of these phenotypic alteration are not fully understood. We report here alterations in the spectrum of integrins, including two fibronectin receptors, on oncogenic transformation of rodent cells. Transformation of rat1, NRK, and Nil8 cells by Rous sarcoma virus or by murine sarcoma viruses encoding ras oncogenes leads to reductions in the level of integrin alpha 5 beta 1, which is a well-defined fibronectin receptor, and of two other integrin receptors. In contrast, another receptor, alpha 3 beta 1, which is a polyspecific receptor for fibronectin, laminin, and collagen, is retained by transformed cells. These results provide explanations for earlier results concerning the interactions of extracellular matrix proteins with the surfaces of tumor cells and offer leads to further understanding of the altered adhesive and migratory behavior of malignant cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2521461     DOI: 10.1016/0092-8674(89)90902-1

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  136 in total

1.  Transformation of chicken embryo fibroblasts by v-src uncouples beta1 integrin-mediated outside-in but not inside-out signaling.

Authors:  A Datta; Q Shi; D E Boettiger
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

2.  Mechanisms underlying abnormal trafficking of malignant progenitors in chronic myelogenous leukemia. Decreased adhesion to stroma and fibronectin but increased adhesion to the basement membrane components laminin and collagen type IV.

Authors:  C M Verfaillie; J B McCarthy; P B McGlave
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

3.  Regulation of collagen I gene expression by ras.

Authors:  J L Slack; M I Parker; V R Robinson; P Bornstein
Journal:  Mol Cell Biol       Date:  1992-10       Impact factor: 4.272

4.  Genetic mapping of the gene coding for the integrin beta 7 subunit to the distal part of mouse chromosome 15.

Authors:  Q Yuan; C A Kozak; W M Jiang; D Hollander; J D Watson; G W Krissansen
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

5.  Integrin expression in human melanoma cells with differing invasive and metastatic properties.

Authors:  K R Gehlsen; G E Davis; P Sriramarao
Journal:  Clin Exp Metastasis       Date:  1992-03       Impact factor: 5.150

Review 6.  Cell-matrix interactions during tumor invasion.

Authors:  J R Starkey
Journal:  Cancer Metastasis Rev       Date:  1990-09       Impact factor: 9.264

7.  Growth suppression of transformed cells by a human placental extract not related to transforming growth factor beta.

Authors:  J L Klein; E Hamel; J L Tayot; H Yamasaki
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

8.  Characterization of integrin subunits, cellular adhesion and tumorgenicity of four human prostate cell lines.

Authors:  C M Witkowski; I Rabinovitz; R B Nagle; K S Affinito; A E Cress
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

9.  Distribution of VLA integrins in solid tumors. Emergence of tumor-type-related expression. Patterns in carcinomas and sarcomas.

Authors:  M Miettinen; R Castello; E Wayner; R Schwarting
Journal:  Am J Pathol       Date:  1993-04       Impact factor: 4.307

Review 10.  Bi-directional signaling: extracellular matrix and integrin regulation of breast tumor progression.

Authors:  Scott Gehler; Suzanne M Ponik; Kristin M Riching; Patricia J Keely
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2013       Impact factor: 1.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.